Table 1 Pre- and perioperative characteristics of AVIE cohort.
From: Surgical treatment and outcomes in aortic valve endocarditis and perivalvular abscesses
Variable | All patients (n = 218), % | Abscess (n = 64), % | No Abscess (n = 154), % | p-value |
|---|---|---|---|---|
Age | 56.9 +/- 14.7 | 53.7 +/- 14.2 | 58.3 +/- 14.8 | 0.558 |
Male | 177 (81.2) | 52 (81.3) | 125 (81.2) | 0.989 |
Previous cardiac surgery | 85 (39.0) | 38 (59.4) | 47 (30.5) | < 0.001 |
Hypertension | 123 (56.4) | 39 (60.9) | 84 (54.5) | 0.474 |
Hyperlipidemia | 84 (38.5) | 22 (34.4) | 62 (40.3) | 0.51 |
CKD | 33 (15.1) | 10 (15.6) | 23 (14.9) | 0.294 |
Dialysis | 16 (7.34) | 4 (6.25) | 12 (7.79) | 0.91 |
COPD | 27 (12.4) | 11 (17.2) | 16 (10.4) | 0.245 |
Redo endocarditis surgery | 33 (15.1) | 20 (31.3) | 11 (7.14) | < 0.001 |
Aortocavitary fistula | 21 (9.63) | 16 (25.0) | 5 (3.25) | < 0.001ara> |
Stroke during endocarditis episode | 62 (28.4) | 29 (45.3) | 53 (34.4) | 0.174 |
Distal emboli | 52 (23.9) | 15 (23.4) | 37 (24.0) | 0.999 |
New HF | 74 (33.9) | 23 (35.9) | 51 (33.1) | 0.758 |
Heart block | 26 (11.9) | 14 (21.9) | 12 (7.79) | 0.0071 |
Prosthetic valve endocarditis | 58 (26.6) | 30 (46.9) | 28 (18.2) | < 0.001 |
Abscess not detected on preoperative imaging | N/A | 15 (23.4) | N/A | N/A |
Positive blood culture during surgery | 23 (10.6) | 6 (9.38) | 17 (11.0) | 0.755 |
Positive tissue culture during surgery | 53 (24.3) | 17 (26.6) | 36 (23.4) | 0.257 |
CPB bypass time | 167 +/- 88.8 | 216 +/- 108 | 147 +/- 70.5 | 0.0738 |
Crossclamp time | 124 +/- 61.7 | 161 +/- 71.9 | 109 +/- 49.7 | 0.116 |
Concomitant procedures | 130 (59.6) | 38 (59.4) | 92 (59.7) | 0.919 |
